Gilead Sciences, Inc. (GILD) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-09 (expected, time not announced). EPS estimate 1.24, revenue estimate 8.30B.
Over the last 12 reports the stock moved 4.4% on average (either way), rising 7 times and falling 5. EPS beat estimates 11 of 12 times; revenue 11 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | 2.55 | 2.19 | +16.4% | 8.30B | 7.81B | +7.2% |
| Q2 FY2026 | 2026-08-03 | -6.75 | -7.25 | +6.9% | 7.80B | 7.40B | +3.9% |
| Q1 FY2026 | 2026-05-07 | 2.03 | 1.91 | +6.3% | 6.96B | 6.91B | -3.6% |
| Q4 FY2025 | 2026-02-10 | 1.86 | 1.81 | +2.8% | 7.93B | 7.69B | +2.7% |
| Q3 FY2025 | 2025-10-30 | 2.47 | 2.13 | +16.0% | 7.77B | 7.45B | +1.1% |
| Q2 FY2025 | 2025-08-07 | 2.01 | 1.96 | +2.6% | 7.08B | 6.98B | +8.3% |
| Q1 FY2025 | 2025-04-24 | 1.81 | 1.78 | +1.7% | 6.67B | 6.81B | -3.0% |
| Q4 FY2024 | 2025-02-11 | 1.90 | 1.74 | +9.2% | 7.57B | 7.15B | +8.2% |